Human Pathology, ISSN 0046-8177, 2010, Volume 41, Issue 1, pp. 1 - 15
Summary This review article summarizes our current understanding of the clinical, pathologic, immunohistochemical, and genetic aspects of perivascular...
Pathology | Perivascular epithelioid cell neoplasms | Immunohistochemistry | mTOR pathway | Sarcoma | GENOTYPE-PHENOTYPE CORRELATIONS | PATHOLOGY | SOFT-TISSUE | MYOMELANOCYTIC TUMOR | MICRONODULAR PNEUMOCYTE HYPERPLASIA | SMOOTH-MUSCLE | TUBEROUS SCLEROSIS COMPLEX | SUGAR TUMOR | RENAL ANGIOMYOLIPOMA | PULMONARY LYMPHANGIOLEIOMYOMATOSIS | OF-THE-LITERATURE | Perivascular Epithelioid Cell Neoplasms - etiology | Soft Tissue Neoplasms - etiology | Biomarkers, Tumor - analysis | Humans | Male | Epithelioid Cells - chemistry | Perivascular Epithelioid Cell Neoplasms - pathology | Soft Tissue Neoplasms - chemistry | Soft Tissue Neoplasms - pathology | Female | Perivascular Epithelioid Cell Neoplasms - chemistry | Epithelioid Cells - pathology | Tumors | Studies | Pathogenesis | Smooth muscle | Muscular system | Chromosomes | Hemorrhage
Pathology | Perivascular epithelioid cell neoplasms | Immunohistochemistry | mTOR pathway | Sarcoma | GENOTYPE-PHENOTYPE CORRELATIONS | PATHOLOGY | SOFT-TISSUE | MYOMELANOCYTIC TUMOR | MICRONODULAR PNEUMOCYTE HYPERPLASIA | SMOOTH-MUSCLE | TUBEROUS SCLEROSIS COMPLEX | SUGAR TUMOR | RENAL ANGIOMYOLIPOMA | PULMONARY LYMPHANGIOLEIOMYOMATOSIS | OF-THE-LITERATURE | Perivascular Epithelioid Cell Neoplasms - etiology | Soft Tissue Neoplasms - etiology | Biomarkers, Tumor - analysis | Humans | Male | Epithelioid Cells - chemistry | Perivascular Epithelioid Cell Neoplasms - pathology | Soft Tissue Neoplasms - chemistry | Soft Tissue Neoplasms - pathology | Female | Perivascular Epithelioid Cell Neoplasms - chemistry | Epithelioid Cells - pathology | Tumors | Studies | Pathogenesis | Smooth muscle | Muscular system | Chromosomes | Hemorrhage
Journal Article
Nature Medicine, ISSN 1078-8956, 11/2015, Volume 21, Issue 11, pp. 1262 - 1271
Cancer-associated muscle weakness is a poorly understood phenomenon, and there is no effective treatment. Here we find that seven different mouse models of...
MEDICINE, RESEARCH & EXPERIMENTAL | CANCER CACHEXIA | CELLS | INTRACELLULAR CALCIUM | BIOCHEMISTRY & MOLECULAR BIOLOGY | RELEASE | CELL BIOLOGY | DYSTROPHIC MUSCLE | GROWTH-FACTOR-BETA | HORMONE-RELATED PROTEIN | RYANODINE RECEPTOR | CAMURATI-ENGELMANN-DISEASE | IN-VIVO | Neoplasms - metabolism | Prostatic Neoplasms - metabolism | Up-Regulation | Calcium - metabolism | Humans | Lung Neoplasms - metabolism | NADPH Oxidases - metabolism | Bone Neoplasms - secondary | Lung Neoplasms - pathology | Male | Muscle, Skeletal - metabolism | Osteolysis - etiology | Ryanodine Receptor Calcium Release Channel - metabolism | X-Ray Microtomography | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Neoplasms - complications | MCF-7 Cells | Osteolysis - diagnostic imaging | Muscle Proteins - metabolism | NADPH Oxidases - genetics | Female | Camurati-Engelmann Syndrome - metabolism | Muscle Strength | Calcium Signaling | Disease Models, Animal | Muscle Weakness - etiology | Prostatic Neoplasms - pathology | Oxidation-Reduction | Bone Neoplasms - diagnostic imaging | NADPH Oxidase 4 | Mice, SCID | Multiple Myeloma - metabolism | Absorptiometry, Photon | Osteolysis - metabolism | Multiple Myeloma - pathology | Animals | Muscle Contraction | Breast Neoplasms - pathology | Mice, Nude | Muscle Weakness - metabolism | Cell Line, Tumor | Mice | Neoplasms - pathology | Transforming Growth Factor beta - metabolism
MEDICINE, RESEARCH & EXPERIMENTAL | CANCER CACHEXIA | CELLS | INTRACELLULAR CALCIUM | BIOCHEMISTRY & MOLECULAR BIOLOGY | RELEASE | CELL BIOLOGY | DYSTROPHIC MUSCLE | GROWTH-FACTOR-BETA | HORMONE-RELATED PROTEIN | RYANODINE RECEPTOR | CAMURATI-ENGELMANN-DISEASE | IN-VIVO | Neoplasms - metabolism | Prostatic Neoplasms - metabolism | Up-Regulation | Calcium - metabolism | Humans | Lung Neoplasms - metabolism | NADPH Oxidases - metabolism | Bone Neoplasms - secondary | Lung Neoplasms - pathology | Male | Muscle, Skeletal - metabolism | Osteolysis - etiology | Ryanodine Receptor Calcium Release Channel - metabolism | X-Ray Microtomography | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Neoplasms - complications | MCF-7 Cells | Osteolysis - diagnostic imaging | Muscle Proteins - metabolism | NADPH Oxidases - genetics | Female | Camurati-Engelmann Syndrome - metabolism | Muscle Strength | Calcium Signaling | Disease Models, Animal | Muscle Weakness - etiology | Prostatic Neoplasms - pathology | Oxidation-Reduction | Bone Neoplasms - diagnostic imaging | NADPH Oxidase 4 | Mice, SCID | Multiple Myeloma - metabolism | Absorptiometry, Photon | Osteolysis - metabolism | Multiple Myeloma - pathology | Animals | Muscle Contraction | Breast Neoplasms - pathology | Mice, Nude | Muscle Weakness - metabolism | Cell Line, Tumor | Mice | Neoplasms - pathology | Transforming Growth Factor beta - metabolism
Journal Article
American Journal of Clinical Nutrition, ISSN 0002-9165, 10/2013, Volume 98, Issue 4, pp. 1012 - 1019
Background: Skeletal muscle wasting is considered the central feature of cachexia, but the potential for skeletal muscle anabolism in patients with advanced...
TOMOGRAPHY | SKELETAL-MUSCLE | NUTRITION & DIETETICS | DOUBLE-BLIND TRIAL | RESECTION | TISSUE | SARCOPENIA | BODY-COMPOSITION | PROTEIN-SYNTHESIS | Body Composition | Muscular Atrophy | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Tomography, X-Ray Computed | Neoplasms - complications | Cachexia - etiology | Female | Cholangiocarcinoma - complications | Pancreatic Neoplasms - pathology | Adipose Tissue - pathology | Neoplasms - mortality | Survival Rate | Metabolism | Lung Neoplasms - complications | Cholangiocarcinoma - pathology | Cachexia - pathology | Cachexia - therapy | Aged | Colorectal Neoplasms - complications | Muscle, Skeletal - pathology | Colorectal Neoplasms - pathology | Neoplasm Staging | Neoplasms - pathology | Longitudinal Studies | Pancreatic Neoplasms - complications | Physiological aspects | Muscles | Complications and side effects | Cachexia | Research
TOMOGRAPHY | SKELETAL-MUSCLE | NUTRITION & DIETETICS | DOUBLE-BLIND TRIAL | RESECTION | TISSUE | SARCOPENIA | BODY-COMPOSITION | PROTEIN-SYNTHESIS | Body Composition | Muscular Atrophy | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Tomography, X-Ray Computed | Neoplasms - complications | Cachexia - etiology | Female | Cholangiocarcinoma - complications | Pancreatic Neoplasms - pathology | Adipose Tissue - pathology | Neoplasms - mortality | Survival Rate | Metabolism | Lung Neoplasms - complications | Cholangiocarcinoma - pathology | Cachexia - pathology | Cachexia - therapy | Aged | Colorectal Neoplasms - complications | Muscle, Skeletal - pathology | Colorectal Neoplasms - pathology | Neoplasm Staging | Neoplasms - pathology | Longitudinal Studies | Pancreatic Neoplasms - complications | Physiological aspects | Muscles | Complications and side effects | Cachexia | Research
Journal Article
European Urology, ISSN 0302-2838, 2013, Volume 65, Issue 4, pp. 778 - 792
Abstract Context The European Association of Urology (EAU) guidelines panel on Muscle-invasive and Metastatic bladder cancer (BCa) updates its guidelines...
Urology | EAU guidelines | Cystectomy | Chemotherapy | Bladder sparing treatments | Comorbidities | Cisplatin-based | Infiltrative | Bladder cancer | Invasive | Quality of life | LYMPH-NODE DISSECTION | BACILLUS-CALMETTE-GUERIN | UROTHELIAL CARCINOMA | LONG-TERM-SURVIVAL | CISPLATIN-BASED CHEMOTHERAPY | PHASE-III TRIAL | TRANSITIONAL-CELL-CARCINOMA | RADICAL CYSTECTOMY | UROLOGY & NEPHROLOGY | QUALITY-OF-LIFE | ELDERLY-PATIENTS | Muscle Neoplasms - diagnosis | Muscle Neoplasms - therapy | Neoplasm Metastasis | Neoplasm Invasiveness | Urinary Bladder Neoplasms - diagnosis | Humans | Muscle Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Urinary Bladder Neoplasms - pathology | Combined Modality Therapy | Neoplasm Staging | Cystectomy - methods | Metastasis | Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Clinical Medicine
Urology | EAU guidelines | Cystectomy | Chemotherapy | Bladder sparing treatments | Comorbidities | Cisplatin-based | Infiltrative | Bladder cancer | Invasive | Quality of life | LYMPH-NODE DISSECTION | BACILLUS-CALMETTE-GUERIN | UROTHELIAL CARCINOMA | LONG-TERM-SURVIVAL | CISPLATIN-BASED CHEMOTHERAPY | PHASE-III TRIAL | TRANSITIONAL-CELL-CARCINOMA | RADICAL CYSTECTOMY | UROLOGY & NEPHROLOGY | QUALITY-OF-LIFE | ELDERLY-PATIENTS | Muscle Neoplasms - diagnosis | Muscle Neoplasms - therapy | Neoplasm Metastasis | Neoplasm Invasiveness | Urinary Bladder Neoplasms - diagnosis | Humans | Muscle Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Urinary Bladder Neoplasms - pathology | Combined Modality Therapy | Neoplasm Staging | Cystectomy - methods | Metastasis | Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Clinical Medicine
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2012, Volume 7, Issue 11, p. e50058
Background: Power morcellation has become a common technique for the minimally invasive resection of uterine leiomyomas. This technique is associated with...
SURGERY | SUPRACERVICAL HYSTERECTOMY | MALIGNANCY | LAPAROSCOPIC MYOMECTOMY | LEIOMYOSARCOMA | MULTIDISCIPLINARY SCIENCES | TISSUE | LEIOMYOMATOSIS | PARASITIC MYOMAS | Leiomyoma - pathology | Peritoneum - pathology | Uterine Neoplasms - surgery | Leiomyosarcoma - pathology | Neoplasm Seeding | Leiomyoma - surgery | Uterine Neoplasms - pathology | Humans | Leiomyosarcoma - surgery | Adult | Female | Uterine Neoplasms - diagnosis | Biological products | Endometrial cancer | Sarcoma | Health aspects | Stem cells | Mesenchyme | Invasiveness | Mortality | Medical records | Muscles | Smooth muscle | Laparoscopy | Malignancy | Fibroids | Hysterectomy | Medical diagnosis | Neoplasms | Uterus | Consultation | Endometrium | Tumors | Peritoneum
SURGERY | SUPRACERVICAL HYSTERECTOMY | MALIGNANCY | LAPAROSCOPIC MYOMECTOMY | LEIOMYOSARCOMA | MULTIDISCIPLINARY SCIENCES | TISSUE | LEIOMYOMATOSIS | PARASITIC MYOMAS | Leiomyoma - pathology | Peritoneum - pathology | Uterine Neoplasms - surgery | Leiomyosarcoma - pathology | Neoplasm Seeding | Leiomyoma - surgery | Uterine Neoplasms - pathology | Humans | Leiomyosarcoma - surgery | Adult | Female | Uterine Neoplasms - diagnosis | Biological products | Endometrial cancer | Sarcoma | Health aspects | Stem cells | Mesenchyme | Invasiveness | Mortality | Medical records | Muscles | Smooth muscle | Laparoscopy | Malignancy | Fibroids | Hysterectomy | Medical diagnosis | Neoplasms | Uterus | Consultation | Endometrium | Tumors | Peritoneum
Journal Article
Cancer Cell, ISSN 1535-6108, 02/2014, Volume 25, Issue 2, pp. 152 - 165
Muscle-invasive bladder cancers (MIBCs) are biologically heterogeneous and have widely variable clinical outcomes and responses to conventional chemotherapy....
BREAST-CANCER | CELLS | ONCOLOGY | PROGNOSIS | UROTHELIAL CARCINOMA | RADICAL CYSTECTOMY | GENE-EXPRESSION | CLASSIFICATION | MICROARRAYS | P63 | PROGRESSION | CELL BIOLOGY | Receptors, Estrogen - metabolism | Urinary Bladder Neoplasms - classification | Cell Proliferation | Prognosis | Carcinoma, Squamous Cell - pathology | Humans | Muscle Neoplasms - pathology | Muscle Neoplasms - classification | Male | Gene Expression Profiling | Vinblastine - administration & dosage | PPAR gamma - metabolism | Receptor, Fibroblast Growth Factor, Type 3 - metabolism | Tumor Suppressor Protein p53 - genetics | Cisplatin - administration & dosage | Urinary Bladder Neoplasms - pathology | Female | Neoadjuvant Therapy | Cell Differentiation | Muscle Neoplasms - drug therapy | Real-Time Polymerase Chain Reaction | Doxorubicin - administration & dosage | PPAR gamma - genetics | Receptor, Fibroblast Growth Factor, Type 3 - genetics | Receptors, Estrogen - genetics | Neoplasm Invasiveness | RNA, Messenger - genetics | Carcinoma, Basal Cell - pathology | Urinary Bladder Neoplasms - drug therapy | Mutation - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Drug Resistance, Neoplasm - genetics | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Basal Cell - drug therapy | Methotrexate - administration & dosage | Aged | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Neoplasm Staging | Clinical Trials, Phase II as Topic | Cohort Studies | Chemotherapy | Anthracyclines | Estrogen | Methotrexate | Tumor proteins | Bladder cancer | Cancer
BREAST-CANCER | CELLS | ONCOLOGY | PROGNOSIS | UROTHELIAL CARCINOMA | RADICAL CYSTECTOMY | GENE-EXPRESSION | CLASSIFICATION | MICROARRAYS | P63 | PROGRESSION | CELL BIOLOGY | Receptors, Estrogen - metabolism | Urinary Bladder Neoplasms - classification | Cell Proliferation | Prognosis | Carcinoma, Squamous Cell - pathology | Humans | Muscle Neoplasms - pathology | Muscle Neoplasms - classification | Male | Gene Expression Profiling | Vinblastine - administration & dosage | PPAR gamma - metabolism | Receptor, Fibroblast Growth Factor, Type 3 - metabolism | Tumor Suppressor Protein p53 - genetics | Cisplatin - administration & dosage | Urinary Bladder Neoplasms - pathology | Female | Neoadjuvant Therapy | Cell Differentiation | Muscle Neoplasms - drug therapy | Real-Time Polymerase Chain Reaction | Doxorubicin - administration & dosage | PPAR gamma - genetics | Receptor, Fibroblast Growth Factor, Type 3 - genetics | Receptors, Estrogen - genetics | Neoplasm Invasiveness | RNA, Messenger - genetics | Carcinoma, Basal Cell - pathology | Urinary Bladder Neoplasms - drug therapy | Mutation - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Drug Resistance, Neoplasm - genetics | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Basal Cell - drug therapy | Methotrexate - administration & dosage | Aged | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Neoplasm Staging | Clinical Trials, Phase II as Topic | Cohort Studies | Chemotherapy | Anthracyclines | Estrogen | Methotrexate | Tumor proteins | Bladder cancer | Cancer
Journal Article
Modern Pathology, ISSN 0893-3952, 2011, Volume 24, Issue 1, pp. 82 - 89
Cellular angiofibroma represents a rare benign mesenchymal tumor, occurring mainly in the superficial soft tissue of the genital region. The involvement of...
genital mesenchymal tumors | soft tissue | spindle cell lipoma | mammary-type myofibroblastoma | cellular angiofibroma | MESENCHYMAL TUMOR | ANGIOMYOFIBROBLASTOMA | FEMALE GENITAL-TRACT | SARCOMATOUS TRANSFORMATION | PATHOLOGY | SOFT-TISSUE | BENIGN NEOPLASM DISTINCT | SOLITARY FIBROUS TUMOR | AGGRESSIVE ANGIOMYXOMA | CLINICOPATHOLOGICAL ANALYSIS | SUPERFICIAL ANGIOMYXOMA | Antigens, CD34 - metabolism | Humans | Middle Aged | Lipoma - genetics | Angiofibroma - metabolism | Male | Lipoma - pathology | Breast Neoplasms - metabolism | Angiofibroma - genetics | Urogenital Neoplasms - metabolism | Vulvar Neoplasms - pathology | Neoplasms, Muscle Tissue - metabolism | Gene Deletion | Vulvar Neoplasms - metabolism | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Lipoma - metabolism | DNA, Neoplasm - analysis | Soft Tissue Neoplasms - genetics | Neoplasms, Muscle Tissue - pathology | Retinoblastoma Protein - metabolism | Soft Tissue Neoplasms - metabolism | Urogenital Neoplasms - pathology | In Situ Hybridization, Fluorescence | Neoplasms, Muscle Tissue - genetics | Breast Neoplasms - genetics | Vulvar Neoplasms - genetics | Breast Neoplasms - pathology | Retinoblastoma Protein - genetics | Urogenital Neoplasms - genetics | Angiofibroma - pathology | Soft Tissue Neoplasms - pathology | Aged
genital mesenchymal tumors | soft tissue | spindle cell lipoma | mammary-type myofibroblastoma | cellular angiofibroma | MESENCHYMAL TUMOR | ANGIOMYOFIBROBLASTOMA | FEMALE GENITAL-TRACT | SARCOMATOUS TRANSFORMATION | PATHOLOGY | SOFT-TISSUE | BENIGN NEOPLASM DISTINCT | SOLITARY FIBROUS TUMOR | AGGRESSIVE ANGIOMYXOMA | CLINICOPATHOLOGICAL ANALYSIS | SUPERFICIAL ANGIOMYXOMA | Antigens, CD34 - metabolism | Humans | Middle Aged | Lipoma - genetics | Angiofibroma - metabolism | Male | Lipoma - pathology | Breast Neoplasms - metabolism | Angiofibroma - genetics | Urogenital Neoplasms - metabolism | Vulvar Neoplasms - pathology | Neoplasms, Muscle Tissue - metabolism | Gene Deletion | Vulvar Neoplasms - metabolism | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Lipoma - metabolism | DNA, Neoplasm - analysis | Soft Tissue Neoplasms - genetics | Neoplasms, Muscle Tissue - pathology | Retinoblastoma Protein - metabolism | Soft Tissue Neoplasms - metabolism | Urogenital Neoplasms - pathology | In Situ Hybridization, Fluorescence | Neoplasms, Muscle Tissue - genetics | Breast Neoplasms - genetics | Vulvar Neoplasms - genetics | Breast Neoplasms - pathology | Retinoblastoma Protein - genetics | Urogenital Neoplasms - genetics | Angiofibroma - pathology | Soft Tissue Neoplasms - pathology | Aged
Journal Article
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, ISSN 1438-9029, 11/2018, Volume 190, Issue 11, pp. 1006 - 1009
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Ileal Neoplasms - diagnostic imaging | Image Enhancement | Humans | Muscle Neoplasms - pathology | Laryngeal Neoplasms - diagnostic imaging | Male | Stomach Neoplasms - pathology | Tomography, X-Ray Computed | Plasmacytoma - pathology | Laryngeal Neoplasms - pathology | Sensitivity and Specificity | Female | Liver Neoplasms - pathology | Breast Neoplasms - diagnostic imaging | Retroperitoneal Neoplasms - pathology | Vitreous Body - diagnostic imaging | Ileal Neoplasms - pathology | Eye Neoplasms - diagnostic imaging | Diagnosis, Differential | Muscle Neoplasms - diagnostic imaging | Stomach Neoplasms - diagnostic imaging | Eye Neoplasms - pathology | Orbital Neoplasms - diagnostic imaging | Orbital Neoplasms - pathology | Mammography | Mediastinal Neoplasms - diagnostic imaging | Liver Neoplasms - diagnostic imaging | Magnetic Resonance Imaging | Retroperitoneal Neoplasms - diagnostic imaging | Breast Neoplasms - pathology | Mediastinal Neoplasms - pathology | Plasmacytoma - diagnostic imaging | Vitreous Body - pathology
Journal Article
RADIOGRAPHICS, ISSN 0271-5333, 09/2004, Volume 24, Issue 5, pp. 1433 - 1466
Benign lipomatous lesions involving soft tissue are common musculoskeletal masses that are classified into nine distinct diagnoses: lipoma, lipomatosis,...
LARGE REFERRAL POPULATION | SHOULDER GIRDLE LIPOMATOSIS | lipoma and lipomatosis | RADIOLOGIC-PATHOLOGICAL CORRELATION | WELL-DIFFERENTIATED LIPOSARCOMA | LIPOSCLEROSING MYXOFIBROUS TUMOR | SPINDLE-CELL LIPOMA | SOFT-TISSUE TUMORS | INTRAOSSEOUS LIPOMA | bone neoplasms | soft tissues , neoplasms | OF-THE-LITERATURE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | MULTIPLE SYMMETRIC LIPOMATOSIS | Neoplasms, Adipose Tissue - diagnostic imaging | Soft Tissue Neoplasms - diagnosis | Humans | Middle Aged | Muscle Neoplasms - pathology | Child, Preschool | Infant | Male | Tomography, X-Ray Computed | Lipoma - pathology | Lipomatosis - diagnostic imaging | Bone Neoplasms - pathology | Muscle Neoplasms - diagnosis | Soft Tissue Neoplasms - diagnostic imaging | Adult | Female | Peripheral Nervous System Neoplasms - pathology | Child | Neoplasms, Adipose Tissue - pathology | Peripheral Nervous System Neoplasms - diagnostic imaging | Neoplasms, Adipose Tissue - classification | Bone Neoplasms - diagnosis | Muscle Neoplasms - diagnostic imaging | Bone Neoplasms - diagnostic imaging | Incidental Findings | Neoplasms, Adipose Tissue - diagnosis | Peripheral Nervous System Neoplasms - diagnosis | Magnetic Resonance Imaging | Adolescent | Lipomatosis - diagnosis | Soft Tissue Neoplasms - pathology | Lipoma - diagnostic imaging | Aged | Lipoma - diagnosis
LARGE REFERRAL POPULATION | SHOULDER GIRDLE LIPOMATOSIS | lipoma and lipomatosis | RADIOLOGIC-PATHOLOGICAL CORRELATION | WELL-DIFFERENTIATED LIPOSARCOMA | LIPOSCLEROSING MYXOFIBROUS TUMOR | SPINDLE-CELL LIPOMA | SOFT-TISSUE TUMORS | INTRAOSSEOUS LIPOMA | bone neoplasms | soft tissues , neoplasms | OF-THE-LITERATURE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | MULTIPLE SYMMETRIC LIPOMATOSIS | Neoplasms, Adipose Tissue - diagnostic imaging | Soft Tissue Neoplasms - diagnosis | Humans | Middle Aged | Muscle Neoplasms - pathology | Child, Preschool | Infant | Male | Tomography, X-Ray Computed | Lipoma - pathology | Lipomatosis - diagnostic imaging | Bone Neoplasms - pathology | Muscle Neoplasms - diagnosis | Soft Tissue Neoplasms - diagnostic imaging | Adult | Female | Peripheral Nervous System Neoplasms - pathology | Child | Neoplasms, Adipose Tissue - pathology | Peripheral Nervous System Neoplasms - diagnostic imaging | Neoplasms, Adipose Tissue - classification | Bone Neoplasms - diagnosis | Muscle Neoplasms - diagnostic imaging | Bone Neoplasms - diagnostic imaging | Incidental Findings | Neoplasms, Adipose Tissue - diagnosis | Peripheral Nervous System Neoplasms - diagnosis | Magnetic Resonance Imaging | Adolescent | Lipomatosis - diagnosis | Soft Tissue Neoplasms - pathology | Lipoma - diagnostic imaging | Aged | Lipoma - diagnosis
Journal Article
Carcinogenesis, ISSN 0143-3334, 05/2015, Volume 36, Issue 5, pp. 528 - 537
The urological cancer-related miR-145, -143 and -224 were deregulated in bladder cancer and especially in aggressive tumors. Overexpression of miR-143/145...
ONCOLOGY | UROTHELIAL CARCINOMA | GROWTH | DISEASE | DOWN-REGULATION | TUMOR-SUPPRESSOR | CELL-PROLIFERATION | RECURRENCE | IDENTIFICATION | EXPRESSION | MICRORNA SIGNATURES | Prognosis | Follow-Up Studies | Humans | Muscle Neoplasms - pathology | Urinary Bladder - pathology | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Case-Control Studies | Neoplasm Recurrence, Local - pathology | Muscle Neoplasms - mortality | Neoplasm Grading | Urinary Bladder Neoplasms - genetics | Muscle Neoplasms - genetics | Urinary Bladder Neoplasms - pathology | Real-Time Polymerase Chain Reaction | Urinary Bladder Neoplasms - mortality | Muscle Neoplasms - surgery | Urinary Bladder - metabolism | Neoplasm Invasiveness | Survival Rate | Urinary Bladder Neoplasms - surgery | Neoplasm Recurrence, Local - genetics | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Neoplasm Staging | Index Medicus
ONCOLOGY | UROTHELIAL CARCINOMA | GROWTH | DISEASE | DOWN-REGULATION | TUMOR-SUPPRESSOR | CELL-PROLIFERATION | RECURRENCE | IDENTIFICATION | EXPRESSION | MICRORNA SIGNATURES | Prognosis | Follow-Up Studies | Humans | Muscle Neoplasms - pathology | Urinary Bladder - pathology | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Case-Control Studies | Neoplasm Recurrence, Local - pathology | Muscle Neoplasms - mortality | Neoplasm Grading | Urinary Bladder Neoplasms - genetics | Muscle Neoplasms - genetics | Urinary Bladder Neoplasms - pathology | Real-Time Polymerase Chain Reaction | Urinary Bladder Neoplasms - mortality | Muscle Neoplasms - surgery | Urinary Bladder - metabolism | Neoplasm Invasiveness | Survival Rate | Urinary Bladder Neoplasms - surgery | Neoplasm Recurrence, Local - genetics | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Neoplasm Staging | Index Medicus
Journal Article
Cell, ISSN 0092-8674, 2009, Volume 139, Issue 7, pp. 1315 - 1326
Cancer cells that leave the primary tumor can seed metastases in distant organs, and it is thought that this is a unidirectional process. Here we show that...
HUMDISEASE | BREAST-CANCER | LUNG METASTASIS | MELANOMA | ANGIOGENESIS | INFLAMMATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENES | DISSEMINATION | INTERLEUKIN-6 | FASCIN | IL-6 | CELL BIOLOGY | Prognosis | Neoplastic Cells, Circulating - pathology | Humans | Neoplasm Recurrence, Local | Melanoma - pathology | Neoplasm Proteins - metabolism | Animals | Breast Neoplasms - pathology | Skin Neoplasms - genetics | Mice | Mice, Inbred BALB C | Neoplasms - physiopathology | Neoplasms - pathology | Collagenases | Colon cancer | Actin | Cancer cells | Melanoma | Metastasis | Muscle proteins | Cancer | Semiochemicals
HUMDISEASE | BREAST-CANCER | LUNG METASTASIS | MELANOMA | ANGIOGENESIS | INFLAMMATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENES | DISSEMINATION | INTERLEUKIN-6 | FASCIN | IL-6 | CELL BIOLOGY | Prognosis | Neoplastic Cells, Circulating - pathology | Humans | Neoplasm Recurrence, Local | Melanoma - pathology | Neoplasm Proteins - metabolism | Animals | Breast Neoplasms - pathology | Skin Neoplasms - genetics | Mice | Mice, Inbred BALB C | Neoplasms - physiopathology | Neoplasms - pathology | Collagenases | Colon cancer | Actin | Cancer cells | Melanoma | Metastasis | Muscle proteins | Cancer | Semiochemicals
Journal Article